Inventor
WILLIAMS BRIAN JOHN
GB37 patents
⚠️ This page may combine multiple inventors who share the name “WILLIAMS BRIAN JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
26 patentsUS6172077B1Jan 9, 2001
Spiro-azacyclic derivatives and their use as therapeutic agents
MERCK SHARP & DOHME149 citations97
US6060469AMay 9, 2000
Spiro-piperidine derivatives and their use as tachykinin antagonists
MERCK SHARP & DOHME42 citations93
US6114315ASep 5, 2000
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
MERCK SHARP & DOHME26 citations92
US5977104ANov 2, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME29 citations92
US5952315ASep 14, 1999
Use of NK-1 receptor antagonists for treating bipolar disorders
MERCK SHARP & DOHME34 citations92
US7138400B2Nov 21, 2006
Sulfamides as gamma-secretase inhibitors
MERCK SHARP & DOHME32 citations91
US6984663B2Jan 10, 2006
Cyclohexyl sulphones
MERCK SHARP & DOHME11 citations83
US6271230B1Aug 7, 2001
Use of NK-1 receptor antagonists for treating cognitive disorders
MERCK SHARP & DOHME6 citations74
US6071927AJun 6, 2000
Spiro-piperidine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME13 citations74
US5925627AJul 20, 1999
Use of NK-1 receptor antagonists for treating movement disorders
MERCK SHARP & DOHME7 citations74
US6489343B2Dec 3, 2002
Tetrahydropyran derivatives and their use as therapeutic agents
MERCK SHARP & DOHME9 citations73
US6100256AAug 8, 2000
Use of NK-1 receptors antagonists for treating schizophrenic disorders
MERCK SHARP & DOHME7 citations73
US5985874ANov 16, 1999
Substituted morpholine derivative and its use as a therapeutic agent
MERCK SHARP & DOHME10 citations73
US7304094B2Dec 4, 2007
Cyclohexyl sulphones
MERCK SHARP & DOHME7 citations72
US6087348AJul 11, 2000
Use of NK-1 receptor antagonists for treating stress disorders
MERCK SHARP & DOHME3 citations63
US5968934AOct 19, 1999
Morpholine derivatives and their use as therapeutic agents
MERCK SHARP & DOHME2 citations63
US5919781AJul 6, 1999
Use of NK-1 receptor antogonists for treating substance use disorders
MERCK SHARP & DOHME5 citations63
US6964981B2Nov 15, 2005
Tetrahydrofuran derivatives and their use as NK-1 antagonists
MERCK SHARP & DOHME3 citations62
US6458830B1Oct 1, 2002
Tetrahydropyran derivatives and their use as therapeutic agents
MERCK SHARP & DOHME7 citations62
US7595344B2Sep 29, 2009
Sulphones which modulate the action of gamma secretase
MERCK SHARP & DOHME2 citations60
US6096729AAug 1, 2000
Use of NK-1 receptor antagonists for treating amnestic disorders
MERCK SHARP & DOHME0 citations52
US7410964B2Aug 12, 2008
Cyclohexyl sulphones as gamma-secretase inhibitors
MERCK SHARP & DOHME0 citations51
US7342009B2Mar 11, 2008
Cyclic sulfonamides for inhibition of gamma-secretase
MERCK SHARP & DOHME0 citations51
US6613765B1Sep 2, 2003
Use of NK-1 receptor antagonists for treating major depressive disorders
MERCK SHARP & DOHME0 citations51
US7598386B2Oct 6, 2009
Sulphones which modulate the action of gamma-secretase
MERCK SHARP & DOHME0 citations50
US7265110B2Sep 4, 2007
Tetrahydropyran derivatives and their use as therapeutic agents
MERCK SHARP & DOHME0 citations41
MERCK & CO INC
5 patentsUS5719147AFeb 17, 1998
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC193 citations99
US6235735B1May 22, 2001
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC19 citations93
US6048859AApr 11, 2000
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC26 citations93
US5872116AFeb 16, 1999
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC14 citations74
US6638930B2Oct 28, 2003
Morpholine and thiomorpholine tachykinin receptor antagonists
MERCK & CO INC1 citations63